Milgamma N (Benfotiamine, Cyanocobalamin, Pyridoxine Hydrochloride)

Benfotiamine is a lipid‑soluble form of thiamine that enhances transketolase activity in carbohydrate metabolism. Cyanocobalamin is converted to active cobalamin cofactors that are essential for DNA synthesis and myelin formation. Pyridoxine is transformed into pyridoxal‑5′‑phosphate, a co‑enzyme for amino‑acid metabolism and neurotransmitter synthesis. Together they act as co‑enzymes that support metabolic pathways and nerve function.

The appropriate dose of Milgamma N is determined by the prescribing healthcare professional based on the individual’s clinical condition, age, weight and other medications. Dosage regimens can vary, and patients should follow the prescriber’s instructions without self‑adjusting the amount.

Safety data for Milgamma N in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before starting the supplement.

To order Milgamma N, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature requirements) and the necessary import documentation.

Milgamma N combines a lipid‑soluble thiamine derivative (benfotiamine) with cyanocobalamin (vitamin B12) and pyridoxine (vitamin B6), offering a broader metabolic profile than many standard B‑complex tablets that contain only water‑soluble forms. This formulation may provide enhanced cellular uptake of thiamine and targeted support for nerve health.

Milgamma N should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability.

Milgamma N is taken orally. Swallow the tablet whole with a glass of water, with or without food, as directed by the prescriber. Consistency with meals may improve tolerance for some individuals.

Serious risks, although rare, include allergic reactions such as rash, itching, swelling, anaphylaxis, severe skin conditions like Stevens‑Johnson syndrome, significant worsening of neuropathy, and hematologic abnormalities such as pancytopenia. Any signs of these reactions require immediate medical attention.

Milgamma N should be avoided by individuals with known hypersensitivity to benfotiamine, cyanocobalamin, pyridoxine or any excipients in the tablet. Patients with severe renal impairment should only use it under medical supervision, and anyone advised by a healthcare professional to refrain from vitamin B supplementation should not take the product.